Clinicopathologic and prognostic significance of CD24 in gallbladder carcinoma

Pathology and Oncology Research

Volumn 17, Issue 1, 2011, Pages 45-50

  Liu, Bo ^a,b   Zhang, Yangde ^b   Liao, Mingmei ^b   Deng, Zhansheng ^b,c   Gong, Liansheng ^b   Jiang, Jiarui ^a   Lynn, Ling ^a   Wu, Kai ^c   Miao, Xiongying ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

CD24; Clinicopathology; Gallbladder carcinoma; Prognosis

Indexed keywords

CD24 ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BILIARY TRACT SURGERY; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; FEMALE; GALLBLADDER CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTION; PROGNOSIS; PROTEIN TARGETING; TISSUE SECTION;

ADULT; AGED; ANTIGENS, CD24; CARCINOMA; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 79952701454     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-010-9278-2     Document Type: Article

References (30)

1. Roa I, De Aretxabala X, Araya JC et al (2006) Preneoplastic lesions in gallbladder cancer. J Surg Oncol 93:615-623 (Pubitemid 43855690)
2. Lewis JT, Talwalkar JA, Rosen CB et al (2003) Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasiacarcinoma sequence. Am J Surg Pathol 31:907-913 (Pubitemid 47165145)
3. Misra S, Chaturvedi A, Misra NC et al (2003) Carcinoma of the gallbladder. Lancet Oncol 4:167-176 (Pubitemid 36322307)
4. Taguchi T, Kiyokawa N, Mimori K et al (2003) Pre-B cell antigen receptor-mediated signal inhibits CD24-induced apoptosis in human pre-B cells. J Immunol 170:252-260 (Pubitemid 36026147)
5. Jung KC, Park WS, Kim HJ et al (2004) TCR independent and caspase-independent apoptosis of murine thymocytes by CD24 cross-linking. J Immunol 172:795-802 (Pubitemid 38113735)
6. Kristiansen G, Sammar M, Altevogt P (2004) Tumor biological aspects of CD24, a mucin-like adhesion molecule. J Mol Histol 35:255-262 (Pubitemid 40585311)
7. Friederichs J, Zeller Y, Hafezi-Moghadam A et al (2000) The CD24/P-selectin binding pathway initiates lung arrest of human A125 adenocarcinoma cells. Cancer Res 60:6714-6722
8. Schindelmann S, Windisch J, Grundmann R et al (2002) Expression profiling of mammary carcinoma cell lines: correlation of in vitro invasiveness with expression of CD24. Tumor Biol 23:139-145 (Pubitemid 44858305)
9. Senner V, Sturm A, Baur I et al (1999) CD24 promotes invasion of glioma cells in vivo. J Neuropathol Exp Neurol 58:795-802 (Pubitemid 29372834)
10. Kristiansen G, Schluns K, Yonwei Y et al (2003) CD24 is an independent prognostic marker of survival in non-small cell lung cancer patients. Br J Cancer 88:231-235
11. Kristiansen G, Winzer KJ, Mayordomo E et al (2003) CD24 expression is a new prognostic marker in breast cancer. Clin Cancer Res 9:4906-4913 (Pubitemid 37323297)
12. Kristiansen G, Pilarsky C, Pervan J et al (2004) CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer. Prostate 58:183-192 (Pubitemid 38160906)
13. Su MC, Hsu C, Kao HL et al (2006) CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma. Cancer Lett 235:34-39
14. Weichert W, Denkert C, Burkhardt M et al (2005) Cytoplasmic CD24 expression in colorectal cancer independently correlates with shortened patient survival. Clin Cancer Res 11:6574-6581 (Pubitemid 41338997)
15. Kristiansen G, Denkert C, Karsten S et al (2002) CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival. Am J Pathol 161:1215-1221
16. Winkler A, Zigeuner R, Rehak P et al (2007) CD24 expression in urothelial carcinoma of the upper urinary tract correlates with tumour progression. Virchows Arch 450:59-64 (Pubitemid 46360738)
17. Fan YZ, Zhang JT, Yang HC et al (2002) Expression of MMP-2, TIMP-2 protein and the ratio of MMP-2/TIMP-2 in gallbladder carcinoma and their significance.World J Gastroenterol 8:1138-1143
18. Taner CB, Nagorney DM, Donohue JH (2004) Surgical treatment of gallbladder cancer. J Gastrointest Surg 8:83-89 (Pubitemid 38117281)
19. Ma HB, Hu HT, Di ZL et al (2005) Association of cyclin D1, p16 and retinoblastoma protein expressions with prognosis and metastasis of gallbladder carcinoma. World J Gastroenterol 11:744-747
20. Aigner S, Ramos CL, Hafezi-Moghadam A et al (1998) CD24 mediates rolling of breast carcinoma cells on P-selectin. FASEB J 12:1241-1251 (Pubitemid 28418954)
21. Lim SC (2005) CD24 and human carcinoma: tumor biological aspects. Biomed Pharmacother 59:351-354
22. Zhang Y, Yao F, Yao X et al (2009) Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24-phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression. Oncol Rep 21:1113-1121
23. Welsh JB, Zarrinkar PP, Sapinoso LM et al (2001) Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc Natl Acad Sci USA 98:1176-1181 (Pubitemid 32121206)
24. Sagiv E, Memeo L, Karin A et al (2006) CD24 is a new oncogene, early at the multistep process of colorectal cancer carcinogenesis. Gastroenterology 131:630-639 (Pubitemid 44142443)
25. Sagiv E, Arber N (2008) The novel oncogene CD24 and its arising role in the carcinogenesis of the GI tract: from research to therapy. Exp Rev Gastroenterol Hepatol 2:125-1233
26. Huang LR, Hsu HC (1995) Cloning and expression of CD24 gene in human hepatocellular carcinoma: a potential early tumor marker gene correlates with p53 mutation and tumor differentiation. Cancer Res 55:4717-4721
27. Lee JH, Kim SH, Lee ES et al (2009) CD24 overexpression in cancer development and progression: a meta-analysis. Oncol Rep 22:1149-1156
28. Jacob J, Bellach J, Grutzmann R et al (2004) Expression of CD24 in adenocarcinomas of the pancreas correlates with higher tumor grades. Pancreatology 4:454-460 (Pubitemid 39140446)
29. Park JS, Jung WH, Kim JK et al (2009) Estrogen receptor α, estrogen receptor β, and progesterone receptor as possible prognostic factor in radically resected gallbladder carcinoma. J Surg Res 152:104-110
30. Varga M, Obrist P, Schneeberger S et al (2004) Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival. Clin Cancer Res 10:3131-3136 (Pubitemid 38619694)